Jeffrey R Jay - Net Worth and Insider Trading

Jeffrey R Jay Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey R Jay owns 6 companies in total, including Foamix Pharmaceuticals Ltd (FOMX) , Adamas Pharmaceuticals Inc (ADMS) , and Connecture Inc (CNXR) among others .

Click here to see the complete history of Jeffrey R Jay’s form 4 insider trades.

Insider Ownership Summary of Jeffrey R Jay

Ticker	Comapny	Transaction Date	Type of Owner
FOMX	Foamix Pharmaceuticals Ltd	2018-09-13	other: Former 10% Owner
ADMS	Adamas Pharmaceuticals Inc	2017-06-19	10 percent owner
CNXR	Connecture Inc	2015-06-30	10 percent owner
		2007-10-15	10 percent owner
		2006-03-21	10 percent owner
		2004-12-14	10 percent owner

Jeffrey R Jay Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeffrey R Jay Ownership Network

Ownership Network List of Jeffrey R Jay

No Data

Ownership Network Relation of Jeffrey R Jay

Jeffrey R Jay Owned Company Details

What does Foamix Pharmaceuticals Ltd do?

Who are the key executives at Foamix Pharmaceuticals Ltd?

Jeffrey R Jay is the other: Former 10% Owner of Foamix Pharmaceuticals Ltd. Other key executives at Foamix Pharmaceuticals Ltd include Chief Scientific Officer Iain Stuart , director & CEO David Domzalski , and CLO and General Counsel Mutya Harsch .

Foamix Pharmaceuticals Ltd (FOMX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Foamix Pharmaceuticals Ltd (FOMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Foamix Pharmaceuticals Ltd (FOMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Foamix Pharmaceuticals Ltd (FOMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Foamix Pharmaceuticals Ltd Insider Transactions

No Available Data

What does Adamas Pharmaceuticals Inc do?

Who are the key executives at Adamas Pharmaceuticals Inc?

Jeffrey R Jay is the 10 percent owner of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .

Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adamas Pharmaceuticals Inc Insider Transactions

No Available Data

What does Connecture Inc do?

Who are the key executives at Connecture Inc?

Jeffrey R Jay is the 10 percent owner of Connecture Inc. Other key executives at Connecture Inc include 10 percent owner Francisco Partners Iv, L.p. , 10 percent owner Francisco Partners Iv-a, L.p. , and 10 percent owner Francisco Partners Gp Iv Management Ltd .

Connecture Inc (CNXR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Connecture Inc (CNXR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Connecture Inc (CNXR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Connecture Inc (CNXR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Connecture Inc Insider Transactions

No Available Data

What does InfuSystems Holdings Inc do?

Who are the key executives at InfuSystems Holdings Inc?

Jeffrey R Jay is the 10 percent owner of InfuSystems Holdings Inc. Other key executives at InfuSystems Holdings Inc include Executive VP and CIO Addam Chupa , EVP-Chief HR Officer Jerod Funke , and Executive VP and CFO Barry G Steele .

InfuSystems Holdings Inc (INFU) Insider Trades Summary

Over the past 18 months, Jeffrey R Jay made no insider transaction in InfuSystems Holdings Inc (INFU). Other recent insider transactions involving InfuSystems Holdings Inc (INFU) include a net sale of 177,574 shares made by R. Rimmy Malhotra , a net sale of 25,000 shares made by Gregg Owen Lehman , and a net purchase of 5,000 shares made by Paul Andrew Gendron .

In summary, during the past 3 months, insiders sold 0 shares of InfuSystems Holdings Inc (INFU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 202,574 shares of InfuSystems Holdings Inc (INFU) were sold and 21,300 shares were bought by its insiders, resulting in a net sale of 181,274 shares.

InfuSystems Holdings Inc (INFU)'s detailed insider trading history can be found in Insider Trading Tracker table.

InfuSystems Holdings Inc Insider Transactions

No Available Data

What does AMAG Pharmaceuticals Inc do?

Who are the key executives at AMAG Pharmaceuticals Inc?

Jeffrey R Jay is the 10 percent owner of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .

AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.

AMAG Pharmaceuticals Inc Insider Transactions

No Available Data

What does Navidea Biopharmaceuticals Inc do?

Who are the key executives at Navidea Biopharmaceuticals Inc?

Jeffrey R Jay is the 10 percent owner of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .

Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Navidea Biopharmaceuticals Inc Insider Transactions

No Available Data

Jeffrey R Jay Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey R Jay. You might contact Jeffrey R Jay via mailing address: Great Point Partners, Llc, 165 Mason Street, 3rd Floor, Greenwich Ct 06830.

Discussions on Jeffrey R Jay

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.